About DNA Probe-based Diagnostic
The DNA probe is a basic component in most molecular diagnostic techniques. The DNA probe is a labeled DNA strand synthesized in the laboratory. Its purpose is to hybridize with the target nucleic acid molecule to be identified from a biological sample. A probe is composed of a strand of 30-40 nucleotides called oligonucleotides. These oligonucleotides are labeled with a detector molecule. When hybridization occurs between the probe and the target organism's nucleic acid, the hybrid can be detected through the detector molecule.
Technavio’s analysts forecast the global DNA probe-based diagnostic market to grow at a CAGR of 10.95% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global DNA probe-based diagnostic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sale of DNA probe-based diagnostic products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global DNA Probe-based Diagnostic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• F. Hoffmann La Roche
• GE Healthcare
• Thermo Fisher Scientific
Other prominent vendors
• BD
• Biogenex
• bioMerieux
• Biolegio
• Luminex
• MP Biomedicals
Market driver
• Growing incidence and prevalence of cancer
• For a full, detailed list, view our report
Market challenge
• Highly complex technique
• For a full, detailed list, view our report
Market trend
• Advancement in DNA array
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
PART 05: MARKET LANDSCAPE
• Market size and forecast
• Five forces analysis
PART 06: MARKET SEGMENTATION BY APPLICATION
• Global DNA probe-based diagnostics market by application
• Global DNA probe-based diagnostics market by infectious disease testing
• Global DNA probe-based diagnostics market by cancer testing
• Global DNA probe-based diagnostics market by others
PART 07: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• DNA probe-based diagnostics market in Americas
• DNA probe-based diagnostics market in EMEA
• DNA probe-based diagnostics market in APAC
• Market opportunity
PART 08: DECISION FRAMEWORK
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Advancement in DNA array
• Increase in molecular research activities
• Increasing importance of promotional activities
• Increasing prominence of DNA probe technology in diagnosing vaginitis
PART 11: VENDOR LANDSCAPE
• Competitive scenario
• Investment opportunity
PART 12: KEY VENDOR ANALYSIS
• Abbott Laboratories
• F. Hoffmann La Roche
• GE Healthcare
• Thermo Fisher Scientific
• Other prominent vendors
PART 13: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Primary types of DNA probe assays used for diagnosis
Exhibit 02: Several diagnostic areas depending on DNA probe-based technology
Exhibit 03: Global DNA probe-based diagnostics market: Market overview
Exhibit 04: Global DNA probe-based diagnostics market 2016-2021 ($ billions)
Exhibit 05: Factors impacting the global DNA probe-based diagnostics market
Exhibit 06: Five forces analysis
Exhibit 07: Global DNA probe-based diagnostics market by application 2016-2021 (% share)
Exhibit 08: Global DNA probe-based diagnostics market by infectious disease testing 2016-2021 ($ billions)
Exhibit 09: Global DNA probe-based diagnostics market by cancer testing 2016-2021 ($ billions)
Exhibit 10: Global DNA probe-based diagnostics market by others 2016-2021 ($ billions)
Exhibit 11: Geographical segmentation 2016-2021– Market share
Exhibit 12: Regional comparison
Exhibit 13: DNA probe-based diagnostics market in Americas 2016-2021 ($ billions)
Exhibit 14: DNA probe-based diagnostics market in Americas: Year-over-year growth
Exhibit 15: Top 3 countries in Americas
Exhibit 16: DNA probe-based diagnostics market in EMEA 2016-2021 ($ billions)
Exhibit 17: DNA probe-based diagnostics market in EMEA: Year-over-year growth
Exhibit 18: Top 3 countries in EMEA
Exhibit 19: DNA probe-based diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 20: DNA probe-based diagnostics market in APAC: Year-over-year growth
Exhibit 21: Top 3 countries in APAC
Exhibit 22: Some examples of infectious diseases caused by pathogenic microorganisms
Exhibit 23: Strategic success factors for vendors
Exhibit 24: Investment opportunity mapping
Exhibit 25: Abbott Laboratories: Profile
Exhibit 26: Abbott Laboratories: Strength analysis
Exhibit 27: Abbott Laboratories: Strategy assessment
Exhibit 28: Abbott Laboratories: Opportunity assessment
Exhibit 29: F. Hoffmann-La Roche: Profile
Exhibit 30: F. Hoffmann-La Roche : Strength analysis
Exhibit 31: F. Hoffmann-La Roche strategy assessment
Exhibit 32: F. Hoffmann-La Roche opportunity assessment
Exhibit 33: GE Healthcare: Profile
Exhibit 34: GE Healthcare: Strength analysis
Exhibit 35: GE Healthcare: Strategy assessment
Exhibit 36: GE Healthcare: Opportunity assessment
Exhibit 37: Thermo Fisher Scientific: Profile
Exhibit 38: Thermo Fisher Scientific: Strength analysis
Exhibit 39: Thermo Fisher Scientific: Strategy assessment
Exhibit 40: Thermo Fisher Scientific: Opportunity assessment
